SRx Health Solutions Inc.
SRXH
$0.34
-$0.04-10.67%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -211.45% | -73.17% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -211.45% | -73.17% | |||
| Cost of Revenue | -- | -75.86% | |||
| Gross Profit | -- | -63.69% | |||
| SG&A Expenses | -- | 69.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -226.43% | -40.49% | |||
| Operating Income | 270.12% | -1,014.37% | |||
| Income Before Tax | -- | -614.69% | |||
| Income Tax Expenses | -- | -299.36% | |||
| Earnings from Continuing Operations | -- | -385.81% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 52.28% | -385.81% | |||
| EBIT | 270.12% | -1,014.37% | |||
| EBITDA | 252.70% | -1,509.41% | |||
| EPS Basic | 58.95% | -422.03% | |||
| Normalized Basic EPS | -- | -621.77% | |||
| EPS Diluted | 59.06% | -422.03% | |||
| Normalized Diluted EPS | -- | -621.77% | |||
| Average Basic Shares Outstanding | -4.40% | -6.94% | |||
| Average Diluted Shares Outstanding | -4.40% | -6.94% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||